DB06111ExperimentalSmall molecule
AB192 is a DPP IV enzymatic activity inhibitor.
- Mechanism
- Curator reviewed
Pharmacologically active on Dipeptidyl peptidase 4
- Primary indication
- Investigated for use/treatment in diabetes mellitus type 2.Curator reviewed
- Code names
- AB-192
Resolves to
Targets
What you can answer from here — as of July 03, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with AB192, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account